Quantcast

Latest BD Diagnostics Stories

2014-07-31 08:34:20

- Announces revenues of $2.157 billion, an increase of 5.1 percent, or 4.6 percent on a foreign currency-neutral basis. FRANKLIN LAKES, N.J., July 31, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.157 billion for the third fiscal quarter ended June 30, 2014, representing an increase of 5.1 percent from the prior-year period, or 4.6 percent on a foreign currency-neutral...

2014-07-28 08:29:28

Assays bring an innovative solution to microbiology and molecular labs BALTIMORE, July 28, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE: BDX) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTec(TM) Chlamydia trachomatis (CT) Q(x) Amplified DNA Assay and the BD ProbeTec(TM) Neisseria gonorrhoeae (GC) Q(x) Amplified DNA Assay on the BD Viper(TM) LT System. The BD Viper LT System...

2014-06-11 08:31:01

The BD BACTEC(TM) FX40 Blood Culture Instrument now communicates with the BD EpiCenter(TM) Data Management System, enabling Laboratory Information System connectivity and Blood Volume Monitoring BALTIMORE, June 11, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its launch of the BD BACTEC(TM) FX40 Blood Culture System with connectivity to the BD EpiCenter(TM) Microbiology...

2014-05-20 12:33:30

BD Signs Agreement with Island Health to Install Microbiology Platform by Fourth Quarter 2014 MISSISSAUGA, Ontario, May 20, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, today announced an agreement with Island Health to install the BD Kiestra(TM) Total Lab Automation (TLA) system. This fully-automated microbiology system will be installed at the Island Health's Royal Jubilee Hospital site by the 4th quarter of calendar year...

2014-05-13 16:29:17

Data-driven approach and implementation of BD Vacutainer® Push Button Blood Collection Sets help drive change at Robert Wood Johnson University Hospital FRANKLIN LAKES, N.J., May 13, 2014 /PRNewswire/ -- An article published in the Spring 2014 issue of the Journal of the Association of Occupational Health Professionals in Healthcare discusses how a systematic, data-driven approach and the subsequent adoption of a safety-engineered blood collection set helped Robert Wood Johnson...

2014-05-08 16:33:19

2,000 sq. ft. Interactive Laboratory Environment Expansion Funded by BD Diagnostics BALTIMORE, May 8, 2014 /PRNewswire/ -- The Maryland Science Center's newly expanded and re-imagined space, SciLab, is now open, providing a unique, popular and hands-on laboratory science simulation for visitors. The 2,000-square-foot expansion was partially funded by a $100,000 contribution from BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...

2014-05-07 12:30:27

SPARKS, Md., May 7, 2014 /PRNewswire/ -- BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared BD MAX(TM) Enteric Bacterial Panel for use on the BD MAX System. The BD MAX Enteric Bacterial Panel is a qualitative IVD test detecting DNA from Campylobacter spp. (jejuni and coli), Salmonella spp., Shigella spp. / Enteroinvasive E. coli (EIEC) as well as stx 1 and stx 2...

2014-05-01 08:33:38

- Announces revenues of $2.072 billion, an increase of 3.6 percent, or 5.1 percent on a foreign currency-neutral basis. FRANKLIN LAKES, N.J., May 1, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.072 billion for the second fiscal quarter ended March 31, 2014, representing an increase of 3.6 percent from the prior-year period, or 5.1 percent on a foreign currency-neutral basis....

2014-03-19 08:29:00

BD Veritor(TM) System for Rapid Detection of RSV Receives 510(k) Clearance and CLIA Waiver FRANKLIN LAKES, N.J., March 19, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for nasopharyngeal swab specimens on the BD Veritor(TM) System...

2014-02-25 08:32:06

BD Veritor(TM) System for Rapid Detection of Group A Strep Receives 510(k) Clearance and CLIA Waiver FRANKLIN LAKES, N.J., Feb. 25, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) Waiver from the U.S. Food and Drug Administration (FDA) for the BD Veritor(TM) System for Rapid Detection of...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related